EZZ · ASX

EZZ Life Science Holdings Ltd. (ASX:EZZ)

AU$2.19

 -0.04 (-1.794%)
ASX:Live
18/09/2025 03:16:14 PM
HALO Ords HALO Consensus Value HALO Capital Efficiency GROWTH AUS Consensus Cheap +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EZZ Overview

EZZ Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About EZZ

Website

N/A

Telephone

61.2.9160.2305

Address

Shop 1 No. 55-59 Parramatta Road Lidcombe, New South Wales (NSW) 2141

Description

EZZ Life Science Holdings Ltd. is a genomic life science company, which engages in the business of formulating, producing, marketing, and selling branded health and wellbeing products to retailers and consumers domestically and internationally. It operates through the Brought in Lines and Company Owned segments. It also operates through the following geographical segments: Australia and New Zealand, Mainland China, and Other Countries and Regions. The company was founded by Qi Zhou Qin on September 22, 2015 is headquartered in Lidcombe, Australia.

EZZ Price Chart

Key Stats

Market Cap

AU$105.20M

PE

15.40

EV/EBITDA

8.5

Dividends Overview

DIV Yield

1.4%

Franking

100%

Ex Dividend Date (est.)

16-May-25

Market Data

52 weeks range

Low 1.29 - 4.97

Trade Value (12mth)

AU$62,174.00

1 week

-0.89%

1 month

-10.8%

YTD

-25.17%

1 year

-27.6%

All time high

4.97

Key Fundamentals

EPS 3 yr Growth

371.80%

EBITDA Margin

15.60%

Operating Cashflow

$4m

Free Cash Flow Return

17.60%

ROIC

27.20%

Interest Coverage

375.10

Quick Ratio

5.30

Other Data

Shares on Issue (Fully Dilluted)

47m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-26

Ex Dividend Date (est.)

16-May-25

Next Dividend Pay Date (est.)

17-Jun-25

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EZZ Announcements

Latest Announcements

Date Announcements

29 August 25

Corporate Governance Statement and Appendix 4G

×

Corporate Governance Statement and Appendix 4G

29 August 25

Annual Report to shareholders

×

Annual Report to shareholders

29 August 25

Appendix 4E - Preliminary Final Report

×

Appendix 4E - Preliminary Final Report

29 July 25

Quarterly Activities / Appendix 4C Cashflow Report

×

Quarterly Activities / Appendix 4C Cashflow Report

19 June 25

EZZ Share Cafe Investor Presentation

×

EZZ Share Cafe Investor Presentation

19 June 25

EZZ Launches in US Market and Receives FDA Registrations

×

EZZ Launches in US Market and Receives FDA Registrations

10 June 25

EZZ Enters SE Asia with Multi Year Distribution Agreement

×

EZZ Enters SE Asia with Multi Year Distribution Agreement

06 May 25

Dividend/Distribution - EZZ

×

Dividend/Distribution - EZZ

06 May 25

Interim Dividend Announcement

×

Interim Dividend Announcement

24 April 25

Quarterly Activities/Appendix 4C Cashflow Report

×

Quarterly Activities/Appendix 4C Cashflow Report

11 March 25

EZZ Appoints United States Manufacturing Partner

×

EZZ Appoints United States Manufacturing Partner

26 February 25

Investor Presentation - 1H FY25 Results

×

Investor Presentation - 1H FY25 Results

26 February 25

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

07 February 25

Notice of FY25 Half Year Results and Investor Webinar

×

Notice of FY25 Half Year Results and Investor Webinar

03 February 25

Change of Company Secretary

×

Change of Company Secretary

23 January 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

12 December 24

Change of Director's Interest Notice - x3

×

Change of Director's Interest Notice - x3

12 December 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

11 December 24

Notification regarding unquoted securities - EZZ

×

Notification regarding unquoted securities - EZZ

11 December 24

Application for quotation of securities - EZZ

×

Application for quotation of securities - EZZ

11 December 24

Change of Director's Interest Notice - Mark Qin

×

Change of Director's Interest Notice - Mark Qin

09 December 24

Application for quotation of securities - EZZ

×

Application for quotation of securities - EZZ

25 November 24

Results of Meeting

×

Results of Meeting

25 November 24

Chair's Address to Shareholders

×

Chair's Address to Shareholders

12 November 24

EZZ to be added to MSCI World Micro Cap Index

×

EZZ to be added to MSCI World Micro Cap Index

EZZ Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.08 0.16 0.15 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.08 0.16 0.15 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.1 90.1 -9.8 Lock Lock Lock
     PE X Lock Lock Lock Lock 10.3 0.0 15.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 4.3 1.8 8.5 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.09 0.16 0.19 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.08 0.11 0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 138.0 86.1 15.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock 15.5 5.9 2.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.01 0.02 0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock 217.8 74.8 60.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.8 2.7 1.4 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 17 15 27 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.34 0.48 0.60 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.34 0.48 0.59 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.3 40.7 24.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 43 43 46 Lock Lock Lock
Basic m Lock Lock Lock Lock 43 43 46 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 37 66 67 Lock Lock Lock
     Growth % Lock Lock Lock Lock 147.3 78.9 0.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 23 40 36 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 27 49 46 Lock Lock Lock
     Growth % Lock Lock Lock Lock 318.9 81.2 -7.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 73.2 74.2 68.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 27 26 32 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 5 10 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 172.5 110.7 3.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 12.9 15.2 15.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 5 10 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 181.0 110.5 2.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 12.4 14.6 14.8 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 5 10 11 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 1 3 4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 4 7 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 176.6 91.9 -3.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.8 10.5 10.1 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 4 6 4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -1 -1 -2 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 4 6 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 106.5 46.6 -28.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 3 5 8 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 14 19 21 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 18 26 34 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -13 -19 -21 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 4 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 15 21 28 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 15 21 28 Lock Lock Lock
     Growth % Lock Lock Lock Lock 29.1 45.0 31.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 20.6 27.3 19.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 24.9 32.7 24.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 34.8 53.2 39.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 27.8 38.7 27.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 30.8 34.1 17.6 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock 460.9 408.3 375.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -2.8 -1.9 -2.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -91.6 -88.6 -73.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.8 6.0 5.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.5 5.6 5.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 81.3 76.4 63.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 136.8 147.0 76.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 20.2 32.7 18.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 17.1 15.3 11.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.6 3.2 2.4 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 3.5 3.1 3.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 2.1 2.6 2.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 2.1 2.6 2.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 13.2 15.0 15.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 27.8 39.0 31.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 25.9 30.1 36.4 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 20.6 27.3 19.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 24.9 32.7 24.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 83.2 84.5 72.6 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 20.7 27.6 17.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 21.3 23.9 32.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 18.1 11.2 19.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 39.4 35.1 52.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 32.2 35.0 36.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 7.2 0.1 16.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

16-May-25

DIV Yield

1.4%

Franking Level

100%

DPSg

60.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EZZ Shortsell

Frequently Asked Questions

The current share price of EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$2.19.
The 52-week high share price for EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$4.97.
The 52-week low share price for EZZ Life Science Holdings Ltd. (EZZ:ASX)? is AU$1.29.
The current TTM dividend payout for EZZ Life Science Holdings Ltd. (EZZ:ASX) is 1.40.
The last dividend payment of EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$0.02.
EZZ Life Science Holdings Ltd. (EZZ:ASX) has a franking level of 100.0%.
EZZ Life Science Holdings Ltd. (EZZ:ASX) is classified in the Healthcare.
The current P/E ratio for EZZ Life Science Holdings Ltd. (EZZ:ASX) is 15.40.
The current share price of EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$2.19.
The 52-week high share price for EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$4.97.
The 52-week low share price for EZZ Life Science Holdings Ltd. (EZZ:ASX)? is AU$1.29.
The current TTM dividend payout for EZZ Life Science Holdings Ltd. (EZZ:ASX) is 1.40.
The last dividend payment of EZZ Life Science Holdings Ltd. (EZZ:ASX) is AU$0.02.
EZZ Life Science Holdings Ltd. (EZZ:ASX) has a franking level of 100.0%.
EZZ Life Science Holdings Ltd. (EZZ:ASX) is classified in the Healthcare.
The current P/E ratio for EZZ Life Science Holdings Ltd. (EZZ:ASX) is 15.40.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.